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BACKGROUND: Stem cell-based therapy is one of the newest and evolving techniques in reproductive medicine. The aim of this study was to investigate 
the effect of allogeneic bone marrow mesenchymal stem 
cells (BM-MSCs) transplantation on the testis of busulfan 
induced azoospermia in Balb/C mice.
METHODS: Eighteen adult Balb/C mice were divided 
into three equal groups including control, busulfan and 
busulfan+cell therapy (busul+CT). For induction of 
azoospermia, busulfan and busul+CT groups received two 
injections of 10 mg/Kg of busulfan intraperitoneally with 
21 days interval.  In the cell therapy group 35 days after the 
last injection of busulfan, cluster of differentiation (CD)90+/
CD34-/CD45- BM-MSCs were injected into the efferent 
duct of testis.  Eight weeks after the BM-MSCs therapy, 
mice were sacrificed and tissues were taken for histological 
and histomorphometric evaluations.
RESULTS: In busul+CT group, cellular and total diameters 
and cellular and cross-sectional areas significantly increased 
in comparison to busulfan group (p˂0.001), but there were 
no significant differences between busul+CT and control 
group (p˃0.05). Numerical density and tubular count per area 
unit in busul+CT and control groups were significantly less 
than busulfan group (p˂0.001), but there were no significant 
difference between busul+CT and control group (p˃0.05). 
The luminal diameter and area showed no significant change 
in all groups (p˃0.05). In busul+CT group, spermatogenesis 
index significantly increased when compared to  busulfan 
and control groups (p˂0.001 and p˂0.05, respectively).
CONCLUSION: Histomorphometric findings showed 
CD90+/CD34-/CD45- BM-MSCs transplantation on the 
testis of busulfan-induced azoospermic in Balb/C mice 
recovered spermatogenesis.
KEywORDS: mesenchymal stem cell, cell therapy, 
azoospermia, busulfan, mouse
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Abstract
Introduction
Nowadays one of the problems of human society is the 
infertility problem. Approximately 10 to 15 percent of 
infertility in men is due to obstructive or non-obstructive 
azoospermia.(1) Many efforts are being made today to treat 
azoospermia, especially its non-obstructive type.(2) Cancer 
is one of the most common diseases around the world, and 
in many cases chemotherapy is used to treat it with drugs 
such as busulfan.(3) Infertility resulting from the use of 
drugs such as busulfan in the chemotherapy of people with 
cancer is considered to be a significant concern in medical 
circles.(4) Busulfan (1,4-Butanediol dimethanesulfonate) 
is an anti-neoplasia and DNA alkylated drug used to treat 
myelogenous leukemia and cancer treatments. Although 
busulfan does not destroy all spermatogonia, it can cause 
temporary or permanent infertility.(5)
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 After treatment with busulfan, the most important 
factor in the degeneration of germ cells is the elimination 
of the balance between reproduction and apoptosis and 
germinal epithelium. Animal experiments indicate the 
ability of stem cells to restore fertility after chemotherapy in 
animals.(6) Various sources of use for stem cells are used, 
including embryonic stem cells or pluripotent stem cells, 
but the use of mesenchymal stem cells (MSCs) is of great 
interest because of its ease of access and working with it. 
MSCs can be obtained from various sources such as bone 
marrow, adipose tissue, dental pulp, and menstrual blood, 
all of which have a high ability to differentiate into different 
tissues.(7,8)
 MSCs have been shown to secrete cytokines and 
growth factors that have anti-inflammatory, immune-
modulating, anti-apoptotic, and proliferative effects. 
Some reports confirm the positive effects of MSCs on the 
process of repairing body tissues.(9) Meanwhile, bone 
marrow MSCs (BM-MSCs) have been considered by many 
researchers because of their high ability to differentiate into 
a variety of cell lines.(10)
 The use of BM-MSCs, due to the possibility of proper 
extraction and proliferation, as well as the ability of the 
differentiation of this group of cells into different tissues, 
has made them an appropriate candidate for cell therapy.
(2,5) In this study, the effect of transplantation of cluster 
of differentiation (CD)90+/CD34-/CD45- BM-MSCs on the 
treatment of busulfan induced azoospermia in Balb/C mice 
was investigated.
Methods
Animals
Eighteen male adult Balb/C mice (30±5 g), were provided 
from Laboratory Animal Center of Shiraz University of 
Medical Sciences. The animals were kept at controlled 
temperature (22±2°C), humidity (55±5%) and lightening 
(12 hours light/dark; from 07:00 a.m. to 19 p.m.) They had 
free access to food and water. The study was undertaken 
based on rules and regulations approved by the Ethics 
Committee for Animal Research at Islamic Azad University 
of Shiraz, Iran (Ethical code no: IR.Miau 1396.602).
Experimental Design 
The mice were randomly assigned into three equal groups 
of control, busulfan and busul+CT (n=6 in each group). 
In control group, no busulfan was administered. In 
busulfan and busul+CT groups, two doses of 10 mg/Kg 
Busilvex® busulfan (Pierre Fabre Medicament, Boulogne-
Billancourt, France) with 21 days interval were injected 
intraperitoneally for induction of azoospermia. Based on 
previous studies, the dose of busulfan was designated in 
order to induce azoospermia mice model.(11,12) In the first 
of experiment, the first dose of busulfan (10 mg/Kg) was 
injected. In busulfan and busul+CT therapy groups and 21 
days later the second dose of busulfan (10 mg/Kg) was also 
done, intraperitoneally. In busul+CT group after 35 days 
the second injection, CD90+/CD34-/CD45- BM-MSCs were 
injected into the efferent duct of both testes and 8 weeks 
after the BM-MSCs therapy all groups were sacrificed 
for testes removal. On the day of sampling, the sacrifice 
was undertaken using ether and cervical dislocation. 
For histomorphometric and histological evaluations, the 
removed testes were fixed in 10% formalin buffer.
Stem Cells Extraction and Culture
Stem cells were isolated from femurs of one donor 
euthanized Balb/C mouse. In sterile condition the two 
ends of the bone were cut and injected into the Dulbecco’s 
modified eagle medium (DMEM) without fetal bovine 
serum (FBS) and penicillin-streptomycin antibiotics. 
Bone marrow was collected and then, the falcon contains 
bone marrow cells centrifuged at speeds of 1200 rpm for 
5 minutes, after that, the supernatant phase was removed 
by pipette and the DMEM medium was added to the cells 
in the falcon. Then cell suspension was transferred to 25 
cm2 flask containing DMEM medium with 10% FBS and 
1% penicillin-streptomycin antibiotic. And flask was 
incubated at 37°C and standard humidity and 5% carbon 
dioxide concentration. The culture medium was changed 
after the first 24 hours and then every 72 hours under 
sterile conditions. After increasing the density of the cells 
adhering to the flask to 80%, the cells were passaged using 
trypsin enzyme, adding the trypsin enzyme for 3 minutes; 
the cells sticking to the flask floor were separated. Then, 
to neutralize the effect of trypsin enzyme, 2 mL of culture 
medium containing 10% FBS was added to the flask. Cells 
isolated from the medium were called the first passage, and 
these actions continued until the third passage.(7)
MSC Characterization: Real Time-Polymerase Chain 
Reaction (RT-PCR) Evaluation
To confirm the presence of bone marrow mesenchymal 
stem cells and the absence of hematopoietic stem cells in 
this study, RT-PCR was used. In this regard, the presence 
of CD90, which is a specific protein of mesenchymal stem 
cells and the absence of CD34 and CD45, which are the 
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specific  proteins  of  the  hematopoietic  stem  cells  were 
investigated.
 Cells from the third passage were used. In the first 
step, RNA was extracted by column method using kit. In the 
second step, cDNA was constructed in reverse transcription 
reaction. Then PCR in thermal cycler machine using 
200μM dNTPs, 2.5μM cDNA, 0.5 μM MgCl2, 25 μLTaq 
DNA polymerase, PCR buffer and forward and reverse 
primers CD34,CD45 and CD90 was performed (Table 1). 
The microcentrifuge tubes containing the resultant mixing 
were transferred into thermocycle. Thirty thermal cycles 
were performed as follow: 5 minutes at 95°C for the initial 
denaturation and 30 seconds at 95°C for denaturation were 
performed. 
Osteogenic and Adipogenic Differentiation
After achieving 80% confluence, the CD90+/CD34-/
CD45- BM-MSCs were cultivated in the osteogenic and 
adipogenic differentiation medium. For osteogenic medium, 
DMEM with 15% of FBS, 200 μM L-ascorbic acid (Wako 
Chemicals, Richmond, VA, USA), 100 nM dexamethasone 
(Sigma-Aldrich, St Louis, USA), 10 mM glycerolphosphate 
(Sigma-Aldrich) and for adipogenic medium DMEM with 
15% of FBS, 200 μM indomethacin (Sigma-Aldrich), 
and 100 nM dexamethasone, 100 μM L-ascorbic acid 
and 0.2 mM L-glutamine (Sigma-Aldrich) were used. 
Differentiation medium was changed twice a week for 21 
days. Before staining, the cells were fixed for 10 minutes 
by 10% formalin solution. Alizarin Red staining was used 
to indicate the calcified extracellular matrix and osteogenic 
differentiation  and  for  adipogenic  differentiation  Oil  Red 
O  staining  was  applied  that  specifically  stains  lipid 
droplets.
Surgical and Transplantation Procedures
For CD90+/CD34-/CD45- BM-MSCs Transplantation, 35 
days after last busulfan injection, the mice were anesthetized 
using 5 mg/Kg ketamine (Alfazyne, Woerden, Netherlands) 
and 20 mg/Kg xylasein (Alfazyne). Then, by providing a 
2 cm incision in the posterior abdominal region, access 
to the peritoneum was provided. Then gently without 
damaging to the epididymis, the testicles were immobilized 
by a triangular plastic piece (Figure 1A). To determine the 
injected, BM-MSCs were mixed with sterile trypan blue 
(1:1, v/v). Also, with using a pipette, 100 μL of suspension 
(106 BM-MSCs) was injected into the efferent duct of the 
both testes till most of seminiferous tubules were filled. 
Consequently, the testicle was returned to the abdominal 
cavity and the abdominal wall and skin were stitched 
(Figure 1B).(13)
A B
Figure 1. Transplantation of BM-MSCs in seminiferous tubules of azoospermic mouse. A: To distinguish the translucent efferent 
duct from the fat tissue and the membrane around it, a hard black plastic triangle was placed under the efferent duct; B: After Injection of 
CD90+/CD34-/CD45- BM-MSCs suspension into efferent duct of mouse testis seminiferous tubules were partially filled. White bars, 1 mm.
Gene Name-Direction Primer Sequence
CD34-Forward AATGAGTCTGTTGAGGAA
CD34-Reverse CTGTCTGAAGTAGTAGGC
CD45-Forward AAGTGGATGTCTATGGTTA
CD45-Reverse GAAGGAAGTCTCTGGTAT
CD90-Forward GAAGACAAGGAGCCAGAAC
CD90-Reverse GCAAGGGAAAGAAGAATAAAGG
Table 1. Sequences of RT-PCR primers used to quantify 
the expression of BM-MSCs specific marker (CD90) and 
hematopoietic stem cells’ specific marker (CD45 and CD34) in 
Mouse.
 At next step, annealing was performed at 64°C, 62°C, 
and 61°C for 30 seconds, respectively. Finally, extension 
was accomplished at 72°C for 30 seconds and the final 
polymerization at 72°C for 5 minutes was done. The 
electrophoresis of the PCR product was performed on 1.5% 
agarose gel containing ethidium bromide and the obtained 
bands were evaluated.
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Histomorphometric Assessment
After fixation and alcohol dehydration of testicular tissue, 
it was embedded in paraffin and for tissue section, five 
horizontal cross-sections were conducted as described by 
Panahi, et al. The sections were 5-µm in thickness and 
staining was conducted using hematoxylin-eosin (H&E) 
and was visualized using a light microscope Model CX21 
(Olympus, Tokyo, Japan). The presence of spermatogonia, 
spermatocytes and spermatids were evaluated in all tubules. 
The inner, outer and total diameters were determined 
in all tubules conducting 10 circular transverse sections 
from different regions of the tubules. The total and 
lumen diameters were assessed in transverse sections by 
Dinocapture software version 2.0 (Dino-Eye, San-Chung, 
Taiwan). By taking the average of two diameters at right 
angles including D1+D2/2 and L1+L2/2, the averages of total 
and Lumen diameters of seminiferous tubules (D and L) 
were clarified, respectively.(12)
 By use of the diameter data, the luminal, cellular 
(germinal epithelium) and cross sectional areas were 
determined. In the seminiferous tubules, the cross-sectional 
area (Ac) was evaluated using the equation of Ac=πD2/4; 
where D was considered as the mean diameter of tubules 
and π was regarded as equivalent to 3.142. The seminiferous 
tubulecount per unit area was also determined. The sections 
of seminiferous tubules per unit area were defined by use 
of an unbiased counting frame. In seminiferous tubules, 
numerical density (NV) was considered as a number of 
tubules per unit volume and it was assessed by the following 
equation: NV=NA/D+T, where, NA denotes to the number 
of profiles per unit area, the tubule mean diameter was 
represented by D, and T revealed the mean thickness of the 
section.(12)
 The spermatogenesis index included the presence 
of spermatogenic cells throughout all testicular tissue 
compromising the types of cells, the number of cell 
layers, and the presence of late spermatids in the tubules. 
Therefore, the number of late spermatids if available were 
counted and then seminiferous tubules were classified 
based on the scale of 0-7 regarding spermatogenic potential, 
while the spermatogenesis index was modified. The scale 
of 0 to 7 was defined as follows: 0=no germinal cells; 
1=only spermatogonia cells; 2=both spermatogonia and 
spermatocytes cells; 3=spermatogonia, spermatocytes, 
and less than 50 late spermatids cells per tubule; 
4=spermatogonia, spermatocytes, and 50-74 late spermatids 
cells per tubule; 5=spermatogonia, spermatocytes and 
75-99 late spermatids cells per tubule; 6=spermatogonia, 
spermatocytes and 100-149 late spermatids cells per tubule; 
Results
Morphologically, cells in the third passage have a 
fibroblastic appearance that is one of the main characteristics 
of MSCs (Figure 2A). Also, The results showed that after 
examination of BM-MSCs by RT-PCR the presence of 
surface marker for BM-MSCs (CD90) and the absence 
of surface factors of hematopoietic stem cells (CD34 and 
CD45) were identified (Figure 2B). The presence of calcium 
deposits in osteogenic differentiation  medium  after  21 
days  with  alizarin red staining indicated the characteristics 
of osteoblasts in comparison with control (Figure 2C and 
2D). In the adipogenic differentiation medium, the presence 
of lipid droplets after Oil Red O staining in the same 
period confirmed by the differentiation of these cells into 
adipoblasts as well (Figure 2E).
 Histologic findings showed that in the control 
group, Spermatogenesis was performed completely and 
spermatogenic cells with Sertoli cells were observed in 
seminiferous tubules (Figure 3A). In the busulfan group, the 
spermatogenic cells were significantly reduced, and the large 
vacuoles space were observed in the germinal epithelium 
of seminiferous tubules. A small number of spermatogonial 
cells were located on the basement membrane, and Sertoli 
cells were visible and spermatogenesis was completely 
degraded (Figure 3B). In the busul+CT group, the vacuolate 
space was eliminated, and in most seminiferous tubules, 
there were a variety of cell lines including spermatogonia, 
spermatocyte, spermatid and sperm (Figure 3C).
 Histomorphometric findings showed that Total and 
cellular diameters and cellular and cross-sectional areas were 
significantly increased in busul+CT group in comparison to 
the busulfan group (p<0.001) and there was no significant 
difference in busul+CT and control groups (p>0.05) (Figure 
7= all germinal cell types and more than 150 late spermatids 
cells per tubule.(11,12)
Statistical Analysis
All data were presented as means and standard error (SE). 
Kolmogorov-Smirnov test was performed to normalization 
of data. Statistical analysis was done with one-way ANOVA 
and post-hoc Tukey test by SPSS software ver. 20 (SPSS 
Inc., Chicago, USA). The Mann-Whitney U test was used 
to assess spermatogenesis index. A p-value of less than 
0.05 was regarded statistically significant. The graphs are 
designed by GraphPad Prism software ver. 5.01 (GraphPad 
Software Inc., San Diego, CA, USA).
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Figure 2. Characterization and differentiation of BM-MSCs. A: Agarose gel electrophoresis of products of reverse transcriptase 
polymerase chain reaction (RT-PCR) demonstrated that specific mesenchymal marker exists (CD90) compared with absence of specific 
hematopoietic marker (CD45and CD34) of mouse BM-MSCs; B: Spindle shape morphology of mouse BM-MSCs in passages 1 (×40); C: 
Control group of BM-MSCs in passage 3 (×100); D: BM-MSCs cultivated in osteogenic medium and stained with alizarin red (×100); and 
E: In adipogenic medium and were stained with Oil Red O at day 21 after induction. White bars, 100 μm.
4A, 4B, 4C and 4D, respectively). There was no significant 
difference in the lumen diameter and area in seminiferous 
tubules in all three groups (p>0.05) (Figure 4E and 4F, 
respectively). Spermatogenesis index was significantly 
increased in busul+CT group in comparison to the busulfan 
and control groups (p<0.001 and p˂0.05, respectively) 
(Figure 4G). In the busul+CT and control groups the number 
of tubules per unit area and numerical density of the tubules 
were less than the busulfan group (p<0.001) and there was 
no significant difference in busul+CT and control groups 
(p>0.05) (Figure 4H and 4I, respectively). 
Discussion
Busulfan is a chemotherapeutic agent which is often used 
for the treatment of chronic myeloid leukemia (14) and is 
also used before bone marrow and stem cells transplantation 
(15,16). Busulfan can inhibit cell division by sticking on 
one of DNA strands.(17) Gutierrez, et al., reported that 
compared to Swiss mice, Balb/C mice were more sensitive 
to the toxic effects of busulfan and were not fertile after 
90 days of treatment.(18) Confirming it, Payehdar, et al., 
showed that two doses (10 mg/Kg) of busulfan with 21 
days interval could induce irreversible azoospermia for 
more than 90 days.(11) Busulfan induces apoptosis and 
destroys mitotic  cells  including germ cells leading to 
azoospermia  and  infertility. (12)  Cell  transplantation 
was  shown  as  a  new approach for treatment of disorders 
such as azoospermia.(13) Hormonal therapies or surgical 
interventions were demonstrated with low efficacy in 
treatment of non-obstructive azoospermia.(19) In our study, 
BM-SCs were used in treatment of azoospermic Balb/C 
mice. 
 Cell therapy with MSCs is a new way for treatment of 
some disorders. BM-MSCs are able to differentiate between 
several mesodermal cell lineages including muscle, bone, 
fat, cartilage and other connective tissues cells.(20) MSCs 
secrete growth factors and cytokines that have anti-
inflammatory, immunosuppressive, anti-apoptosis, and 
proliferative effects that called ‘trophic’ activity.(21) Kuo, 
et al., reports that stem cell use improves complications of 
diabetes on the liver.(22) Also, stem cell use can reduce the 
complications of heart attack in pigs.(23) Sadraie, et al., 
showed that BM-MSCs can reduce the side effects of knee 
rubbing in the guinea pig.(24)
 In this study it was shown that transplantation of 
CD90+/CD34-/CD45- BM-MSCs in azoospermic Balb/C 
mice could successfully recover induce spermatogenesis. 
Similar findings demonstrated that Ad-SCs and BM-SCs 
could lead to recovery of fertility in the busulfan-induced 
azoospermia in rat (6,9), hamster (25), and Guinea pigs 
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cells as immune-privileged for successful  cell  transplantation 
without  the need  for  chronic immunosuppression 
therapy. The  immune  protective  nature  of  Sertoli  cells 
has been  presented  in another  study.(32) Sertoli cells 
provide the microenvironment suitable for differentiation 
and proliferation of spermatogonial stem cells. Our 
findings, confirmed that BM-MSCs could reconstitute 
tubular  microenvironment  providing  the chance  for 
remained  inactivated  germinal cells to proliferate in 
the host seminiferous tubules.(25) There is evidence of 
the hypoimmunogenic nature of MSCs and so there is 
implication for allogeneic therapy.(31,33) Intravenous 
injection of BMSCs was shown to have immunosuppressive 
effects on production of anti-sperm antibody in allogeneic 
transfusion in mice after testis rupture.(25)
 Mital, et al., reported that survival and protection of the 
cells after transplantation can be due to the immunological 
tolerance of Sertoli cells.(32) In seminiferous tubules, some 
points can be remarked after transplantation of stem cells: 
1) blood-testis barrier as the immune privilege character 
plays an important role after stem cells transplantation in 
seminiferous tubules (34), 2) Also was shown that BM-MSCs 
(26). Cakici, et al., showed that Ad-SCs transplantation 
after 12 weeks could recover busulfan-treated infertile male 
rats and induce spermatogenesis.(6) Lue, et al., reported that 
transplanted BM-SCs in busulfan-treated infertile mouse 
model could differentiate into germ, Sertoli, and Leydig 
cells.(27)
 Several studies evaluated the differentiation potential 
of MSCs into spermatozoa in mice and rats regarding intra-
seminiferous tubule (2,5) and intra-testicular injection 
of BM-MSCs (28). Monsefi, et al., showed that testis in 
infertile rats receiving BM-SCs could differentiate between 
germ cells in seminiferous tubules.(28) The differentiation 
potential of MSCs to spermatozoa was previously reported 
in rat (2,9,29) and hamster (25). But differentiation did not 
happen in all tubules.(6,9) Also, Nayernia, et al., reported that 
BM-MSCs could differentiation between germ cells in vivo.
(30) Chen, et al., reported that human umbilical cord MSCs 
transplanted into seminiferous tubule of  immunodeficient 
mouse  could  differentiate  between sperm.(31)  It was 
shown that cell transplantation in azoospermic animals 
may be species dependent.(25) Seminiferous tubules are 
responsible for regulation of spermatogenesis,  and Sertoli 
A B
C
Figure 3. Histopathologic evaluation of seminiferous tubule 
in control, busulfan and busul+CT mice. A: Section of 
seminiferous tubules of normal control mouse. spermatogenic 
epithelium was condensed by tubules. B: Busulfan induced 
azoospermic mouse seminiferous tubules. The seminiferous 
tubules were partially empty and vacuolated spaces without 
germinal layer cells showed the lack of spermatogenesis. C: 
Sections of seminiferous tubules of treated mouse with BM-
MSCs. Most of tubules seemed to possess spermatogenic cells. 
White bars, 50 μm (H&E staining).
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Figure 4. Mean and standard error of histomorphometric indices of seminiferous tubules in control, busulfan and busul+CT 
groups. A: Total diameter (μm), B: Cellular diameter (μm), C: Cellular area (μm2), D: Cross sectional area of the tubule (μm2), E: Luminal 
area (μm2), F: Lumen diameter (μm), G: Spermatogenesis index, H: Number of seminiferous tubules per unit area of testicular tissue, I: 
Numerical density of the seminiferous tubules. Different superscripts (a, b and c) indicate statistically differences between groups (p<0.05).
to have both hypoimmunogenic and immunosuppressive 
features after transplantation.(35) Therefore, transplantation 
of MSCs was considered as a method of choice for 
azoospermia cell therapy.
Conclusion
In this current study, histological and histomorphometric 
findings revealed that intra testicular transplantation 
of CD90+/CD34-/CD45- BM-MSCs in seminiferous 
tubules of busulfan-induced azoospermic Balb/C mice 
could differentiate between all types of germinal cells and 
recovered the spermatogenesis. BM-MSCs transplantation 
could be an effective method to treat non-obstructive 
azoospermia in patients undergoing chemotherapy such as 
busulfan and restore fertility in these patients. But more 
research must be done to verify this issue.
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